TODD E SIMPSON Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for TODD E SIMPSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of TODD E SIMPSON. TODD E SIMPSON is a VP, CFO, Treas. & Sec. in AmpliPhi Biosciences Corp ($APHB) and a Chief Financial Officer in SEATTLE GENETICS INC /WA ($SGEN) and a See Remarks in SEATTLE GENETICS INC /WA ($SGEN) and a Director in AQUINOX PHARMACEUTICALS, INC ($AQXP).
Address: 1100 OLIVE WAY SUITE 100 SEATTLE 98101 WA
Companies in which TODD E SIMPSON is an Insider
Armata Pharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of TODD E SIMPSON: VP, CFO, Treas. & Sec.
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 26 2005
$APHB Market Capitalization: $5.61M
$APHB Previous Close: $0.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Neoleukin Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TODD E SIMPSON: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 13 2021
$NLTX Market Capitalization: $451.60M
$NLTX Previous Close: $18.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of TODD E SIMPSON: See Remarks, Chief Financial Officer
Holdings: 152,436 shares
Current Value: $9,266,584
Latest Transaction: Dec 18 2020
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of TODD E SIMPSON
Sentiment: All, APHB, NLTX, SGEN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | NLTX | Neoleukin Therapeu ... | SIMPSON TODD E | Director | Option Exercise | A | 11.40 | 25,000 | 285,000 | 25,000 | |
| Dec 18 2020 | SGEN | Seagen Inc. | SIMPSON TODD E | Chief Financial Off ... | Option Exercise | M | 26.10 | 33,669 | 878,761 | 0 | |
| Dec 18 2020 | SGEN | Seagen Inc. | SIMPSON TODD E | Chief Financial Off ... | Option Exercise | M | 45.30 | 1,104 | 50,011 | 0 | |
| Dec 18 2020 | SGEN | Seagen Inc. | SIMPSON TODD E | Chief Financial Off ... | Buy | M | 45.30 | 1,104 | 50,011 | 119,871 | 118.8 K to 119.9 K (+0.93 %) |
| Dec 18 2020 | SGEN | Seagen Inc. | SIMPSON TODD E | Chief Financial Off ... | Sell | S | 200.00 | 33,669 | 6,733,800 | 118,767 | 152.4 K to 118.8 K (-22.09 %) |
| Dec 18 2020 | SGEN | Seagen Inc. | SIMPSON TODD E | Chief Financial Off ... | Buy | M | 26.10 | 33,669 | 878,761 | 152,436 | 118.8 K to 152.4 K (+28.35 %) |
| Sep 02 2020 | SGEN | SEATTLE GENETICS I ... | SIMPSON TODD E | Chief Financial Off ... | Sell | S | 159.33 | 469 | 74,726 | 126,276 | 126.7 K to 126.3 K (-0.37 %) |